SMAD4 and neoplasm: Here, we found that the tumor growth of Smad4 WT PDAC cells in vivo was not affected by the depletion of immune cells including CD4+, CD8+ T cells or NK cells, suggesting poor immunogenicity of the PDAC tumor cells.